152 related articles for article (PubMed ID: 30101392)
1. Prognostic value of volume-based metabolic parameters of
Han S; Kim H; Kim YJ; Suh CH; Woo S
Ann Nucl Med; 2018 Dec; 32(10):669-677. PubMed ID: 30101392
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-analysis.
Han S; Kim YJ; Woo S; Suh CH; Lee JJ
Clin Nucl Med; 2018 Dec; 43(12):887-894. PubMed ID: 30300200
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Volume-Based Metabolic Parameters of
Han S; Kim H; Kim YJ; Suh CH; Woo S
AJR Am J Roentgenol; 2018 Nov; 211(5):1112-1121. PubMed ID: 30207790
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis.
Zhu D; Wang L; Zhang H; Chen J; Wang Y; Byanju S; Liao M
Medicine (Baltimore); 2017 Aug; 96(33):e7813. PubMed ID: 28816978
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis.
Nie K; Zhang YX; Nie W; Zhu L; Chen YN; Xiao YX; Liu SY; Yu H
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):84-93. PubMed ID: 30230710
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of MTV and TLG of
Wen W; Piao Y; Xu D; Li X
Contrast Media Mol Imaging; 2021; 2021():7528971. PubMed ID: 34887713
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
[TBL] [Abstract][Full Text] [Related]
9. The role of metabolic tumor volume and total lesion glycolysis on ¹⁸F-FDG PET/CT in the prognosis of epithelial ovarian cancer.
Lee JW; Cho A; Lee JH; Yun M; Lee JD; Kim YT; Kang WJ
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1898-906. PubMed ID: 24852188
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with breast cancer: A systematic review and meta-analysis.
Wen W; Xuan D; Hu Y; Li X; Liu L; Xu D
PLoS One; 2019; 14(12):e0225959. PubMed ID: 31826010
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
12. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.
Xie M; Wu K; Liu Y; Jiang Q; Xie Y
Med Oncol; 2015 Jan; 32(1):446. PubMed ID: 25511321
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of baseline
Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.
Jin A; Lin X; Yin X; Cui Y; Ma L
Medicine (Baltimore); 2022 Sep; 101(39):e30798. PubMed ID: 36181127
[TBL] [Abstract][Full Text] [Related]
18. Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer.
Wang D; Koh ES; Descallar J; Pramana A; Vinod SK; Ho Shon I
Asia Pac J Clin Oncol; 2016 Dec; 12(4):349-358. PubMed ID: 27550522
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Total Lesion Glycolysis by
McDonald JE; Kessler MM; Gardner MW; Buros AF; Ntambi JA; Waheed S; van Rhee F; Zangari M; Heuck CJ; Petty N; Schinke C; Thanendrarajan S; Mitchell A; Hoering A; Barlogie B; Morgan GJ; Davies FE
Clin Cancer Res; 2017 Apr; 23(8):1981-1987. PubMed ID: 27698001
[No Abstract] [Full Text] [Related]
20. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]